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Rosmarinic acid (RA), an ester of caffeic acid and 3,4-dihydrophenyllactic acid (Figure 1), is 
a naturally occurring phenylpropanoid that is commonly found in species of the Boraginaceae 
family, the subfamily Nepetoideae of the Lamiaceae family, and in lower plants such as ferns 
and hornworts (Petersen and Simmonds, 2003). RA was first isolated and purified in 1958 
from Rosmarinus officinalis by two Italian chemists, Scarpati and Oriente, who then named it 
according to the plant that they isolated it from (Scarpati and Oriente, 1958). The biosynthesis 
of RA has been extensively studied, and a biosynthetic pathway was first reported in 1970 by 
Ellis and Towers. They demonstrated that two aromatic amino acids - L-tyrosine and L-
phenylalanine - are the building blocks of rosmarinic acid (Ellis and Towers, 1970). 
 
Figure 1: Chemical structure of rosmarinic acid 
 
RA has a range of biological activities, making it an interesting material for the pharmaceuti-
cal, food, and cosmetics industries. Here we summarize key messages of recent studies per-
formed on RA and its biological and pharmacological activities (Table 1).  
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Table 1: Key messages of recent studies performed on RA and its biological and pharmacological 
activities 
Key message Reference 
 
RA was shown to ameliorate cisplatin-induced oxidative stress, in-
flammation, and apoptosis in the kidneys. Domitrović et al., 2014 
RA prevented ischemia/reperfusion injury in the kidneys by decreas-
ing oxidative stress. Ozturk et al., 2014 
RA was found to have protective effects against hyperthermia-
induced cellular apoptosis and damage of muscle cells by changing 
the expression of stress genes and increasing intracellular antioxidant 
capability. 
Chen et al., 2014 
RA showed efficacy in ameliorating some aspects of diabetic neuro-
pathy. Therefore, RA is a good candidate for diabetic neuropathy 
treatment in clinical studies. 
Hasanein and Mohammad 
Zaheri, 2014 
The analgesic effects of the acetyl derivative of RA were found to oc-
cur via a peripherally mediated mechanism. The acetyl ester deriva-
tive of RA is potentially applicable as a new lead compound for the 
management of pain and inflammation. 
Lucarini et al., 2013 
RA protected aortic endothelial function and ultrastructure against 
diabetes-induced damage. Both antioxidant and anti-inflammatory 
effects of RA seemed to have a role in the mechanism of protection. 
Sotnikova et al., 2013 
RA inhibited Cd(2+)-mediated cell toxicity, reactive oxygen species 
generation, interleukin (IL)-6 and IL-1β production, the translocation 
of the apoptosis-inducing factor into the nucleus, and the activation of 
caspase-3 in an auditory cell line, HEI-OC1. In addition, RA prevent-
ed the destruction of hair cell arrays in the rat organ of corti primary 
explants in the presence of Cd(2+).  
Kim et al., 2013 
The data demonstrated that RA protects the brain against I/R (ische-
mia and reperfusion) injury with a favorable therapeutic time-window 
by alleviating diabetic cerebral I/R injury and attenuating the break-
down of the blood-brain barrier (BBB). 
Luan et al., 2013 
The authors believed that RA should be viewed as a possible thera-
peutic agent for the treatment of various inflammatory diseases via 
inhibition of the HMGB1 (high-mobility group box 1) signaling path-
way. 
Yang et al., 2013 
RA showed chemopreventive potential against 1,2-dimethylhydrazine 
(DMH)-induced rat colon carcinogenesis and it is a possible chemo-
preventive agent against colon cancer. 
Venkatachalam et al., 2013 
Chronic consumption of RA resulted in quantifiable levels of parent 
compound in the plasma and intestinal tract of the Apc(Min) mouse 
model of colorectal carcinogenesis, and may slow adenoma devel-
opment.  
Karmokar et al., 2012 
The polyphenol RA showed therapeutic potential in a murine model of 
a respiratory allergy to a clinically relevant human sensitizer allergen. Costa et al., 2012 
RA demonstrated potent anti-inflammatory effects in in vivo models of 
acute lung injury (ALI) induced by lipopolysaccharide (LPS). Chu et al., 2012 
RA had potent anticancer, anti-lipid peroxidative, and apoptotic ef-
fects in DMBA (7,12-dimethylbenz(a)anthracene)-induced skin car-
cinogenesis. 
Sharmila and Manoharan, 
2012 
RA could decrease the levels of DNA damage induced by ethanol. De Oliveira et al., 2012 
Neuroreparative effects of RA were demonstrated against 6-ODHA 
(6-hydroxydopamine)-induced degeneration of the nigrostriatal dopa-
minergic system. They were achieved by decreasing nigral iron levels 
and regulating the ratio of Bcl-2/Bax gene expression. 
Wang et al., 2012 
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Table 1 (cont.): Key messages of recent studies performed on RA and its biological and pharmaco-
logical activities 
Key message 
 
Reference 
 
RA suppressed oral carcinogenesis by stimulating the activity of de-
toxification enzymes, improving the status of lipid peroxidation and 
antioxidants, and downregulating the expression of p53 and bcl-2 dur-
ing DMBA (7,12-dimethylbenz(a)anthracene)-induced oral carcino-
genesis. 
Anusuya and Manoharan, 
2011 
RA acted as a vasoactive substance and a cardioprotector due to its 
antioxidant property. Thus, RA may be useful in reducing the cardio-
vascular risk associated with insulin resistance. 
Karthik et al., 2011 
Antihemorrhage activity of RA was reported for the first time, and RA 
was found to greatly contribute to the antihemorrhagic efficiency of 
Argusia argentea against crude snake venoms and hemorrhagic tox-
ins. 
Aung et al., 2010 
In animal experiments, intraperitoneal administration of 2 mg of ros-
marinic acid significantly reduced the weight of tumors and the num-
ber of lung nodules compared with those of a control group. There-
fore, these results demonstrated that rosmarinic acid can effectively 
inhibit tumor metastasis in vitro and in vivo. 
Xu et al., 2010 
In vivo experiments showed the capacity of orally administered RA to 
inhibit cutaneous alterations caused by UVA exposure (skin photo-
carcinogenesis). According to this research, RA can be considered a 
photo-protective agent. 
Sánchez-Campillo et al., 
2009 
Our investigation into the atopic dermatitis-mitigating effect of RA 
through in vivo experiments demonstrated the possible clinical use of 
RA as a therapeutic agent for atopic dermatitis. 
Lee et al., 2008 
The nitration of RA strongly improved the anti-integrase inhibition and 
the antiviral activity without increasing the cellular toxicity. Dubois et al., 2008 
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